Control_vs_Immune_Tolerant

Profile details

Identifier: MTBLS279_0002_00000001
Linked study: MTBLS279 — Metabolic characterization of the natural progression of chronic hepatitis B (Lipid assays).
Comparison: Control vs Immune Tolerant
Group A: Control group with no HBV infection. Provides baseline metabolic profile for comparison with infected groups.
Group B: Samples in the immune tolerant phase of HBV infection. Helps understand metabolic changes during the immune tolerant phase of HBV infection.
Total features tested: 124
Significant features: 28
p-value threshold: 0.05
Ratio threshold (upper): 1.5
Ratio threshold (lower): 1/1.5
Date created: 2025-09-26 00:00:00

Metabolite ID (InChI Key)	Name	Direction	Ratio	p-value
TZWUYONGXAHBAL-UBTPLURJSA-N	—	up	3.187	0.00126
VUYXIQLBLBPRDY-VOHILQMLSA-N	—	up	2.245	0.00209
YHGXYYIGHBPDMX-BUTFDPNWSA-N	lysophosphatidylcholine(20:3(5<i>Z</i>,8<i>Z</i>,11<i>Z</i>)/0:0)	up	1.776	0.000181
IWXJKHSPEQSQMD-GMGFYYQASA-N	Phosphatidylcholine(14:0/18:2w6)	up	1.806	0.000331
RUOVJPPUXXFZPC-JMWCFZJPSA-N	—	up	2.289	0.00494
MTWYSKGJIDFSRC-SOEJSTAXSA-N	—	up	2.078	0.00253
SRQSAJRUMDQMMS-NLDJLLEISA-N	PC(14:0/20:4)	up	1.936	0.00177
DOEBPNOTMREOMP-FZTZZYPMSA-N	—	up	2.285	0.00729
VXUOFDJKYGDUJI-OAQYLSRUSA-N	1-myristoyl-glycero-3-phosphocholine	up	1.717	0.000718
XWHIBISICRMDDW-ZLBNXBDKSA-N	GPCho(14:0/20:3n9)	up	1.56	0.000296